155 related articles for article (PubMed ID: 8651351)
1. Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma.
Papadaki H; Kounelis S; Kapadia SB; Bakker A; Swalsky PA; Finkelstein SD
Am J Surg Pathol; 1996 Jun; 20(6):715-21. PubMed ID: 8651351
[TBL] [Abstract][Full Text] [Related]
2. The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma.
Papadaki H; Finkelstein SD; Kounelis S; Bakker A; Swalsky PA; Kapadia SB
Hum Pathol; 1996 Jun; 27(6):567-72. PubMed ID: 8666366
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
4. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
Czapiewski P; Kunc M; Haybaeck J
Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
[TBL] [Abstract][Full Text] [Related]
5. The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix.
Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Finkelstein SD
Int J Gynecol Pathol; 1997 Oct; 16(4):301-6. PubMed ID: 9421067
[TBL] [Abstract][Full Text] [Related]
6. Olfactory neuroblastoma (esthesioneuroblastoma) and esthesioneuroepithelioma: histologic and immunohistochemical study.
Taraszewska A; Czorniuk-Sliwa A; Dambska M
Folia Neuropathol; 1998; 36(2):81-6. PubMed ID: 9757618
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
Li X; Liu HG; Xie XJ; Han YD; Li M
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.
Topcagic J; Feldman R; Ghazalpour A; Swensen J; Gatalica Z; Vranic S
PLoS One; 2018; 13(1):e0191244. PubMed ID: 29324814
[TBL] [Abstract][Full Text] [Related]
9. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).
Carney ME; O'Reilly RC; Sholevar B; Buiakova OI; Lowry LD; Keane WM; Margolis FL; Rothstein JL
J Neurooncol; 1995 Oct; 26(1):35-43. PubMed ID: 8583243
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable
Lazo de la Vega L; McHugh JB; Cani AK; Kunder K; Walocko FM; Liu CJ; Hovelson DH; Robinson D; Chinnaiyan AM; Tomlins SA; Harms PW
Mol Cancer Res; 2017 Nov; 15(11):1551-1557. PubMed ID: 28775129
[TBL] [Abstract][Full Text] [Related]
11. p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.
Quintanilla-Martinez L; Kremer M; Keller G; Nathrath M; Gamboa-Dominguez A; Meneses A; Luna-Contreras L; Cabras A; Hoefler H; Mohar A; Fend F
Am J Pathol; 2001 Dec; 159(6):2095-105. PubMed ID: 11733360
[TBL] [Abstract][Full Text] [Related]
12. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
13. Olfactory Neuroblastoma with Divergent Differentiation: An Unusual Histologic Finding in a Rare Tumor.
Meyer C; Hamersley ERS; Manosalva RE; Torske K; McIntyre N; Mitchell A
Head Neck Pathol; 2017 Dec; 11(4):531-536. PubMed ID: 28168398
[TBL] [Abstract][Full Text] [Related]
14. Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.
Wang L; Ding Y; Wei L; Zhao D; Wang R; Zhang Y; Gu X; Wang Z
Medicine (Baltimore); 2016 May; 95(18):e3536. PubMed ID: 27149458
[TBL] [Abstract][Full Text] [Related]
15. Cytopathologic features of olfactory neuroblastoma.
Mahooti S; Wakely PE
Cancer; 2006 Apr; 108(2):86-92. PubMed ID: 16456848
[TBL] [Abstract][Full Text] [Related]
16. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract.
Wooff JC; Weinreb I; Perez-Ordonez B; Magee JF; Bullock MJ
Am J Surg Pathol; 2011 Dec; 35(12):1786-93. PubMed ID: 22020045
[TBL] [Abstract][Full Text] [Related]
17. Odorant receptor genes are expressed in olfactory neuroblastoma.
Gonzalez-Kristeller DC; Gutiyama LM; Campos AH; Soares FA; Brentani H; Malnic B
Genet Mol Res; 2013 Sep; 12(3):3479-87. PubMed ID: 24065686
[TBL] [Abstract][Full Text] [Related]
18. Targeted 595-gene genomic profiling demonstrates low tumor mutational burden in olfactory neuroblastoma.
Friedman J; Schumacher JK; Papagiannopoulos P; Al-Khudari S; Tajudeen BA; Batra PS
Int Forum Allergy Rhinol; 2021 Jan; 11(1):58-64. PubMed ID: 32558242
[TBL] [Abstract][Full Text] [Related]
19. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.
Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA
Mod Pathol; 2024 May; 37(5):100448. PubMed ID: 38369189
[TBL] [Abstract][Full Text] [Related]
20. [Olfactory neuroblastoma with unusual structures: a clinical pathologic study].
Yao Q; Yue CL; Lü ZC; Han YD; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):163-8. PubMed ID: 19575850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]